1Bone Marrow Donor Worldwide. Arailable at http://www.worldmarrow. org.
2Hurley CK, Wade JA, Oudshoorn M, et al. A special report:histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors. Quality Assurance and Donor Registries Working Groups of the World Marrow Donor Association. Hum Immunol, 1999, 60(4) :347.
3Wiegand T, Raffoux C, Hurley CK, et al. A special report:suggested procedures for international unrelated donor search from the donor registries and quality assurance working groups of the World Marrow Donor Association (WMDA). Bone Marrow Transplant, 2004,34(2) :97.
4Hurley CK, Baxter Lowe LA, Logan B, et al. National Marrow Donor Program HLA-matching guidelines for unrelated marrow transplants. Biol Blood Marrow Transplant, 2003, 9(10) :610.
5Tiercy JM, Marsh SG, Schreuder GM, et al. Guidelines for nomenclature usage in HLA reports: ambiguities and conversion to serotypes. EurJ Immunogenet, 2002, 29(3):273.
6Marsh SG, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system, 2002. Tissue Antigens, 2002, 60(5) :407.
7Schreuder GM, Hurley CK, Marsh SG, et al. The HLA Dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Tissue Antigens,2001, 58(2):109.
8Hurley CK, Setterholm M, Lau M, et al. Hematopoietic stem cell donor registry strategies for assigning search determinants and matching relationships. Bone Marrow Transplant, 2004, 33(4) :443.
9Flomenberg N, Baxter-Lowe LA, Confer D, et al. Impact of HLA class I and class Ⅱ high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood, 2004, 104(7): 1923.
10Petersdorf EW, Anasetti C, Martin PJ, et al. Limits of HLA mismatching in unrelated hematopoietic cell transplantation.Blood,2004, 104(9) :2976.
